EVOFEM BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
EVOFEM BIOSCIENCES, INC. (EVFM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2023-04-27
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $0.00.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $47.00K, a 64.66% decline from fiscal 2019.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2019 was $133.00K, a 1008.33% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-04-27 |
| 2021-12-31 | $0.00 10-K · filed 2023-04-27 |
| 2020-12-31 | $47.00K 10-K · filed 2022-03-10 |
| 2019-12-31 | $133.00K 10-K · filed 2021-03-04 |
| 2018-12-31 | $12.00K 10-K · filed 2020-03-12 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-01 |
| 2016-12-31 | $0.00 8-K/A · filed 2018-04-06 |